167 related articles for article (PubMed ID: 31271842)
1. Feasibility of monitoring compliance with intermittent occlusion therapy glasses for amblyopia treatment.
Wang J; Jin J; Malik A; Shoge R; Meiyeppen S; Pang Y; Yin K; Allen M; Scombordi B; Soni A; Neely DE; Januschowski K
J AAPOS; 2019 Aug; 23(4):205.e1-205.e5. PubMed ID: 31271842
[TBL] [Abstract][Full Text] [Related]
2. Intense versus standard regimens of intermittent occlusion therapy for unilateral moderate amblyopia in children: study protocol for a randomized controlled trial.
Wang J; Malik A; Jin J; Pang Y; Yin K; Allen M; Grigorian A; Scombordi B; Bailey J; Aljohani S; Funari K; Shoge R; Meiyeppen S; Myung J; Soni A; Neely DE
Trials; 2020 Apr; 21(1):361. PubMed ID: 32345348
[TBL] [Abstract][Full Text] [Related]
3. A pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopia.
Wang J; Neely DE; Galli J; Schliesser J; Graves A; Damarjian TG; Kovarik J; Bowsher J; Smith HA; Donaldson D; Haider KM; Roberts GJ; Sprunger DT; Plager DA
J AAPOS; 2016 Aug; 20(4):326-31. PubMed ID: 27418249
[TBL] [Abstract][Full Text] [Related]
4. Association Between Adherence to Glasses Wearing During Amblyopia Treatment and Improvement in Visual Acuity.
Maconachie GD; Farooq S; Bush G; Kempton J; Proudlock FA; Gottlob I
JAMA Ophthalmol; 2016 Dec; 134(12):1347-1353. PubMed ID: 27737444
[TBL] [Abstract][Full Text] [Related]
5. [The Use of a Microsensor in Therapy of Amblyopia].
Januschowski K; Rickmann A; Emmerich C; Abaza A; Bechtold TE; Schott TC; Schramm C
Klin Monbl Augenheilkd; 2019 Oct; 236(10):1170-1173. PubMed ID: 29117611
[TBL] [Abstract][Full Text] [Related]
6. Refractive adaptation and efficacy of occlusion therapy in untreated amblyopic patients aged 12 to 40 years.
Simonsz-Tóth B; Joosse MV; Besch D
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):379-389. PubMed ID: 30397791
[TBL] [Abstract][Full Text] [Related]
7. Comparison between over-glasses patching and adhesive patching for children with moderate amblyopia: a prospective randomized clinical trial.
Kim SJ; Jeon H; Jung JH; Lee KM; Choi HY
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):429-437. PubMed ID: 29204689
[TBL] [Abstract][Full Text] [Related]
8. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase.
Loudon SE; Polling JR; Simonsz HJ
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):176-80. PubMed ID: 12644939
[TBL] [Abstract][Full Text] [Related]
9. Measuring wearing times of glasses and ocular patches using a thermosensor device from orthodontics.
Januschowski K; Bechtold TE; Schott TC; Huelber-Januschowski MS; Blumenstock G; Bartz-Schmidt KU; Besch D; Schramm C
Acta Ophthalmol; 2013 Dec; 91(8):e635-40. PubMed ID: 23759025
[TBL] [Abstract][Full Text] [Related]
10. A comparison of Min's glasses and conventional occlusion therapy in the treatment of amblyopic children: a prospective study.
Min BM; Kim SY; Ko KH; Lee SB
Korean J Ophthalmol; 2000 Jun; 14(1):32-7. PubMed ID: 10933016
[TBL] [Abstract][Full Text] [Related]
11. Using liquid crystal glasses to treat ambyopia in children.
Erbağcı I; Okumuş S; Öner V; Coşkun E; Çelik O; Ören B
J AAPOS; 2015 Jun; 19(3):257-9. PubMed ID: 26059673
[TBL] [Abstract][Full Text] [Related]
12. Part-time occlusion therapy for anisometropic amblyopia detected in children eight years of age and older.
Lee YR; Lee JY
Korean J Ophthalmol; 2006 Sep; 20(3):171-6. PubMed ID: 17004632
[TBL] [Abstract][Full Text] [Related]
13. Optimal compliance for amblyopia therapy: occlusion with a translucent tape on the lens.
Beneish RG; Polomeno RC; Flanders ME; Koenekoop RK
Can J Ophthalmol; 2009 Oct; 44(5):523-8. PubMed ID: 19789586
[TBL] [Abstract][Full Text] [Related]
14. [Treatment monitoring and innovations in amblyopia treatment].
Januschowski K; Emmerich C; Abaza A; Julich-Haertel H; Rickmann A
Ophthalmologe; 2019 Dec; 116(12):1231-1234. PubMed ID: 31552468
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified?
Cleary M
Br J Ophthalmol; 2000 Jun; 84(6):572-8. PubMed ID: 10837378
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance.
Awan M; Proudlock FA; Gottlob I
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1435-9. PubMed ID: 15790912
[TBL] [Abstract][Full Text] [Related]
17. An audit of the outcome of amblyopia treatment: a retrospective analysis of 322 children.
Awan M; Proudlock FA; Grosvenor D; Choudhuri I; Sarvanananthan N; Gottlob I
Br J Ophthalmol; 2010 Aug; 94(8):1007-11. PubMed ID: 19955200
[TBL] [Abstract][Full Text] [Related]
18. Treating amblyopia with liquid crystal glasses: a pilot study.
Spierer A; Raz J; Benezra O; Herzog R; Cohen E; Karshai I; Benezra D
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3395-8. PubMed ID: 20164454
[TBL] [Abstract][Full Text] [Related]
19. Compliance in amblyopia therapy: objective monitoring of occlusion.
Fielder AR; Irwin M; Auld R; Cocker KD; Jones HS; Moseley MJ
Br J Ophthalmol; 1995 Jun; 79(6):585-9. PubMed ID: 7626576
[TBL] [Abstract][Full Text] [Related]
20. Interventions for strabismic amblyopia.
Taylor K; Elliott S
Cochrane Database Syst Rev; 2011 Aug; (8):CD006461. PubMed ID: 21833955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
